[1]. Osborn LM, Kamphuis W, Wadman WJ, Hol EM. Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease. Progress in Neurobiology. 2016;144:121-41 .
[2]. Soreq H, Seidman S. Acetylcholinesterase—new roles for an old actor. Nature Reviews Neuroscience. 2001;2(4):294.
[3]. Rochais C, Lecoutey Cd, Gaven F, Giannoni P, Hamidouche K, Hedou D, et al. Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer’s disease: the design of donecopride. Journal of medicinal chemistry. 2015;58(7):3172-87 .
[4]. Santillo MF, Liu Y. A fluorescence assay for measuring acetylcholinesterase activity in rat blood and a human neuroblastoma cell line (SH-SY5Y). Journal of pharmacological and toxicological methods. 2015;76:15-22 .
[5]. Hosseinzadeh S, Jafarikukhdan A, Hosseini A, Armand R. The application of medicinal plants in traditional and modern medicine: a review of Thymus vulgaris. International Journal of Clinical Medicine. 2015;6(09):635-42 .
[6]. Fournomiti M, Kimbaris A, Mantzourani I, Plessas S, Theodoridou I, Papaemmanouil V, et al. Antimicrobial activity of essential oils of cultivated oregano (Origanum vulgare), sage (Salvia officinalis), and thyme (Thymus vulgaris) against clinical isolates of Escherichia coli, Klebsiella oxytoca, and Klebsiella pneumoniae. Microbial ecology in health and disease. 2015;26(1):23289 .
[7]. Nemati Z, Barzegar R, Khosravinezhad M, Talebi E, Safaei HR. Chemical composition and antioxidant activity of Shirazi Thymus vulgaris essential oil. Advanced Herbal Medicine. 2017;3(2):26-32 .
[8]. Asadzadeh A, Fassihi A, Yaghmaei P, Pourfarzam M. Docking studies of some novel kojic acid derivatives as possible tyrosinase inhibitors. Biomedical and Pharmacology Journal. 2015;8(2):535-45 .
[9]. Asadzadeh A, Fassihi A, Yaghmaei P, Pourfarzam M. In silico approach for designing potent inhibitors against tyrosinase. Biotech Res Asia. 2015;12 .
[10]. Asadzadeh A, Sirous H, Pourfarzam M, Yaghmaei P, Afshin F. In vitro and in silico studies of the inhibitory effects of some novel kojic acid derivatives on tyrosinase enzyme. Iranian journal of basic medical sciences. 2016;19(2):132 .
[11]. Komaki A, Hoseini F, Shahidi S, Baharlouei N. Study of the effect of extract of Thymus vulgaris on anxiety in male rats. Journal of traditional and complementary medicine. 2016;6(3):257-61 .
[12]. Esmaeili S, Ara L, Hajimehdipoor H, Kolivand H, Mohammadi Motamed S. Acetylcholinesterase inhibitory effects of some plants from Rosaceae. RJP. 2015;2(4):33-7 .
[13]. Dewanjee S, Gangopadhyay M, Bhattacharya N, Khanra R, Dua TK. Bioautography and its scope in the field of natural product chemistry. Journal of Pharmaceutical Analysis.
2015;5(2):75-84 .
[14]. Tabet N. Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing! Age and ageing. 2006;35(4):336-8 .
[15]. Qiang W, Yau W-M, Lu J-X, Collinge J, Tycko R. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes. Nature. 2017;541(7636):217 .
[16]. GHARIB NMK. Effect of Zataria multiflora Boiss leaf hydroalcoholic extract on rat ileum. 2003 .
[17]. Luo W, Yu Q-s, Kulkarni SS, Parrish DA, Holloway HW, Tweedie D, et al. Inhibition of human acetyl-and butyrylcholinesterase by novel carbamates of (−)-and (+)tetrahydrofurobenzofuran and methanobenzodioxepine. Journal of medicinal chemistry. 2006;49(7):2174-85 .
[18]. Fang J, Wu P, Yang R, Gao L, Li C, Wang D, et al. Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation. Acta Pharmaceutica Sinica B. 2014;4(6):430-7 . [19]. Anand P, Singh B, Singh N. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease.
[20]. Bioorganic & medicinal chemistry. 2012;20(3):1175-80.
[21]. Cao Y, Himmeldirk KB, Qian Y, Ren Y, Malki A, Chen X. Biological and biomedical functions of penta-O-galloyl-Dglucose and its derivatives. Journal of natural medicines. 2014;68(3):465-72.
[22]. Hosseini SA, Moghimi A, Iman M. Design and Docking Study of Novel Oximes as Reactivators of Inhibited Acetylcholinesterase with Nerve Agents. Journal Mil Med. 2018;20(2):170-80.
[23]. Asthana S, Raffaele KC, Berardi A, Greig NH, Haxby JV, Schapiro MB, et al. Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine. Alzheimer disease and associated disorders. 1995.
[24]. Ismaili L, Refouvelet B, Benchekroun M, Brogi S, Brindisi M, Gemma S, et al. Multitarget compounds bearing tacrine-and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease. Progress in neurobiology. 2017;151:4-34.
[25]. Khonakdari MR, Mirjalili MH, Gholipour A, Rezadoost H, Farimani MM. Quantification of galantamine in Narcissus tazetta and Galanthus nivalis (Amaryllidaceae) populations growing wild in Iran. Plant Genetic Resources. 2018;16(2):18892.
[26]. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free radical biology and medicine. 2004;36(7):838-49.
[27]. Nabavi SM, Marchese A, Izadi M, Curti V, Daglia M, Nabavi SF. Plants belonging to the genus Thymus as antibacterial agents: From farm to pharmacy. Food chemistry. 2015;173:33947.